Title:
[1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-ジフルオロフェニル)-シクロプロピルアミノ]-5-(プロピルチオ)-3H-1,2,3-トリアゾロ[4,5-d]ピリミジン-3-イル]-5-(2-ヒドロキシエトキシ)シクロペンタン-1,2-ジオールおよびその中間体の製造方法
Document Type and Number:
Japanese Patent JP2012502024
Kind Code:
A
Abstract:
The present invention is directed to a process for preparing [1S-[1alpha,2alpha,3beta(1S*,2R*),5beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and to intermediates useful in the process.
More Like This:
Inventors:
Aufden Bratten, Ronnie
Borin, Martin Hans
Helstroom, Helena
Johansson, Peter Wee
Larsson, Wolf Geh
Lennagel, Michaela
Weiss, Andreas
Borin, Martin Hans
Helstroom, Helena
Johansson, Peter Wee
Larsson, Wolf Geh
Lennagel, Michaela
Weiss, Andreas
Application Number:
JP2011526012A
Publication Date:
January 26, 2012
Filing Date:
September 08, 2009
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
C07H19/23; C07H9/02; C07H17/02
Domestic Patent References:
JP2002503663A | 2002-02-05 | |||
JP2003535093A | 2003-11-25 | |||
JP2002503663A | 2002-02-05 |
Attorney, Agent or Firm:
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Akiko Nakahama
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Akiko Nakahama